Personalis Shares Outstanding 2018-2023 | PSNL
Personalis shares outstanding from 2018 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Personalis Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
48 |
| 2022 |
46 |
| 2021 |
44 |
| 2020 |
34 |
| 2019 |
18 |
| 2018 |
3 |
| 2017 |
3 |
Personalis Quarterly Shares Outstanding
(Millions of Shares) |
| 2023-12-31 |
48 |
| 2023-09-30 |
49 |
| 2023-06-30 |
48 |
| 2023-03-31 |
47 |
| 2022-12-31 |
46 |
| 2022-09-30 |
46 |
| 2022-06-30 |
46 |
| 2022-03-31 |
45 |
| 2021-12-31 |
44 |
| 2021-09-30 |
45 |
| 2021-06-30 |
44 |
| 2021-03-31 |
42 |
| 2020-12-31 |
34 |
| 2020-09-30 |
35 |
| 2020-06-30 |
32 |
| 2020-03-31 |
31 |
| 2019-12-31 |
18 |
| 2019-09-30 |
31 |
| 2019-06-30 |
7 |
| 2019-03-31 |
3 |
| 2018-12-31 |
|
| 2018-09-30 |
3 |
| 2018-06-30 |
3 |
| 2017-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.063B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
